DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
274	骨形成不全症	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2004-005275-42-IT (EUCTR)	21/03/2005	23/01/2008	Study on the effect of r-hGH in combination with bisphosphonate treatment on bone metabolism in Osteogenesis Imperfecta	Study on the effect of r-hGH in combination with bisphosphonate treatment on bone metabolism in Osteogenesis Imperfecta	Osteogenesis Imperfecta MedDRA version: 6.1;Level: SOC;Classification code 10010331	Trade Name: GENOTROPIN1TBF 5,3MG (16UI) INN or Proposed INN: Somatropin Trade Name: NERIXIAINFUS IV CONC 2F 100MG INN or Proposed INN: VARI	AZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI VERONA	NULL	Not Recruiting			Female: yes Male: yes			Italy

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

21/03/2005

23/01/2008

Study on the effect of r-hGH in combination with bisphosphonate treatment on bone metabolism in Osteogenesis Imperfecta

Osteogenesis Imperfecta
MedDRA version: 6.1;Level: SOC;Classification code 10010331

Trade Name: GENOTROPIN*1TBF 5,3MG (16UI)
INN or Proposed INN: Somatropin
Trade Name: NERIXIA*INFUS IV CONC 2F 100MG
INN or Proposed INN: VARI

AZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI VERONA

NULL

Not Recruiting

Female: yes
Male: yes

Italy